Related Experiment Video
Updated: May 17, 2025

Murine Ileocolic Bowel Resection with Primary Anastomosis
Published on: October 29, 2014
Brown bowel syndrome: a systematic review
Rena Hm Cao1, Jason Diab2,3,4, Michael C Grimm3,5
1Royal Prince Alfred Hospital, Camperdown, NSW, Australia; University of Sydney, Faculty of Medicine (Rena HM Cao).
Brown bowel syndrome (BBS) involves intestinal pigmentation due to lipofuscin. This review of 63 patients found diarrhea and malnutrition as key symptoms, with celiac disease impacting albumin levels and mortality.
Area of Science:
- Gastroenterology
- Rare Diseases
- Histopathology
Background:
- Brown bowel syndrome (BBS) is a rare condition characterized by intestinal brown pigmentation.
- Lipofuscin accumulation is the suspected cause of BBS.
- Celiac disease and vitamin E deficiency are potential risk factors.
Purpose of the Study:
- To systematically review and synthesize clinical information on patients diagnosed with BBS.
- To identify common symptoms, risk factors, and outcomes associated with BBS.
Main Methods:
- Systematic literature search of PubMed, Embase, Web of Science, and Cochrane databases.
- Inclusion of case reports and abstracts with confirmed BBS diagnoses.
- Analysis of clinical data from 63 confirmed BBS patients across 42 studies.
Main Results:
- Diarrhea (50.8%) and malnutrition (50.8%) were the most frequent symptoms.
- Abdominal pain (39.7%) and vomiting (22.2%) were also common.
- BBS patients with celiac disease had lower hypoalbuminemia rates (15.4% vs. 45.5%) and a trend towards higher mortality (36.4% vs. 15.4%).
- Vitamin E deficiency was present in 31.7% of BBS patients, with similar outcomes to those without deficiency.
- Clinical presentation and outcomes were comparable between patients with and without celiac disease or vitamin E deficiency.
Conclusions:
- BBS presents with significant gastrointestinal symptoms like diarrhea and malnutrition.
- Celiac disease may influence BBS patient outcomes, particularly albumin levels and mortality.
- Further research is needed to establish optimal diagnostic and therapeutic strategies for BBS.
Related Concept Videos
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:

